TY - JOUR
T1 - Cutaneous angiosarcoma of breast after lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast carcinoma
T2 - Case report and review of the literature
AU - Mermershtain, Wilmosh
AU - Cohen, Arnon D.
AU - Koretz, Michael
AU - Cohen, Yoram
PY - 2002/12/1
Y1 - 2002/12/1
N2 - Malignant neoplasms known to develop after external beam radiation include angiosarcoma. Although angiosarcoma developing in a lymphedematous arm after radical mastectomy is a well-known phenomenon, cutaneous angiosarcoma after radiotherapy for breast carcinoma has been rarely documented. Herein we present a case with cutaneous angiosarcoma that developed in a 69-year-old woman's breast 5 years after she underwent conservative treatment to the breast: lumpectomy, axillary lymph node dissection, and radiation therapy to the breast. The possible relation of the angiosarcoma to the initial radiotherapy, early diagnosis, and treatment is discussed.
AB - Malignant neoplasms known to develop after external beam radiation include angiosarcoma. Although angiosarcoma developing in a lymphedematous arm after radical mastectomy is a well-known phenomenon, cutaneous angiosarcoma after radiotherapy for breast carcinoma has been rarely documented. Herein we present a case with cutaneous angiosarcoma that developed in a 69-year-old woman's breast 5 years after she underwent conservative treatment to the breast: lumpectomy, axillary lymph node dissection, and radiation therapy to the breast. The possible relation of the angiosarcoma to the initial radiotherapy, early diagnosis, and treatment is discussed.
KW - Angiosarcoma
KW - Primary breast carcinoma
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=0036901134&partnerID=8YFLogxK
U2 - 10.1097/00000421-200212000-00014
DO - 10.1097/00000421-200212000-00014
M3 - Article
C2 - 12478007
AN - SCOPUS:0036901134
SN - 0277-3732
VL - 25
SP - 597
EP - 598
JO - American Journal of Clinical Oncology: Cancer Clinical Trials
JF - American Journal of Clinical Oncology: Cancer Clinical Trials
IS - 6
ER -